§ Funding Round
Series B funding round for Nuvalent raising $140M in May 2021
Series B funding round for Nuvalent raising $140M in May 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
SV Health Investors | — | — |
Avoro Capital Advisors | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Fidelity Management & Research Company | — | — |
Janus Henderson Investors | — | — |
Logos Capital | — | — |
| Organization | — | |
Viking Global Investors | — | — |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$190M
Top Valuation
-
Nuvalent raised $140M in a Series B round.
The round was announced on 05/01/21.
The round was led by Bain Capital Life Sciences.
